Back to Search
VINCENT ADAMO, M.D.
M.D.
Internal Medicine Physician
NPI: 1548244569Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
46430(CO)
Research & Publications (20)
Gefitinib in lung cancer therapy: clinical results, predictive markers of response and future perspectives.
PMID 19182534·Cancer Biol Ther·2009
6-review
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study.
PMID 18493232·Br J Cancer·2008
3-trial
Current knowledge and future directions on bisphosphonate-related osteonecrosis of the jaw in cancer patients.
PMID 18473709·Expert Opin Pharmacother·2008
6-review
Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study).
PMID 17591801·Ann Oncol·2007
3-trial
Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients.
PMID 17591833·Ann Oncol·2007
6-review
Impact of integrated treatments on patient management in solid tumors: from diagnosis to palliative care.
PMID 16873084·Forum (Genova)·2006
8-other
Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy.
PMID 16608991·Ann Oncol·2006
6-review
Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen.
PMID 16319510·Oncology·2005
3-trial
Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
PMID 15006626·Oral Oncol·2004
3-trial
Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis.
PMID 19331179·Anticancer Res·2009
8-other
Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients.
PMID 19536363·Drug News Perspect·2009
6-review
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis.
PMID 19235250·Cancer·2009
4-observational
Comparison of protocols efficacy in poor responders: differences in oocytes/embryos competence with different protocols, a retrospective study.
PMID 18706554·Fertil Steril·2009
4-observational
Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients.
PMID 18689862·Ann Oncol·2009
8-other
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study.
PMID 18796517·J Clin Endocrinol Metab·2008
2-rct
A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck.
PMID 18594217·Anticancer Drugs·2008
3-trial
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome.
PMID 18594003·Clin Cancer Res·2008
8-other
Oral vinorelbine as first line chemotherapy in unfit elderly patients with hormone-refractory prostate cancer.
PMID 18606594·J Chemother·2008
3-trial
Protective effect of leuprolide on ovarian function in young women treated with adjuvant chemotherapy for early breast cancer: a multicenter phase II study.
PMID 19129073·J Chemother·2008
3-trial
Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome.
PMID 19077269·BMC Cancer·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3025 S PARKER RD, SUITE 100
AURORA, CO 80014 - Phone
- (303) 481-7030
Quick Facts
- NPI
- 1548244569
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile